From Lab Bench to Bedside
with Dr. Sue Bruhn
in the Large Meeting Room
Thursday, September 16 - 7:00 p.m.

Due to limited seating, free tickets are required for this event. Tickets may be picked up at the Library, beginning August 16.

The process of bringing a new drug or therapy to market has been described as running a gauntlet. In this program, Dr. Sue Bruhn, Senior Vice President, Strategic Planning and Program Management, Shire Human Genetic Therapies, discusses why this process is so costly, so lengthy and so fraught with risk, and how drug companies manage that process to bring new drugs and therapies to patients. Dr. Bruhn will also discuss the particular challenges of developing treatments for rare diseases.

Integrating Eastern and Western Medicine
with Dr. Danru Lee
in the Large Meeting Room
Thursday, October 7 - 7:30 p.m.

Due to limited seating, free tickets are required for this program. Tickets may be picked up at the Library, beginning September 1.

Dr. Danru Lee is on staff at Beth Israel Deaconess Healthcare in Sharon and is also a Clinical Instructor in Internal Medicine at Harvard Medical School. Board -certified in Internal Medicine, she is a strong proponent of the integration of eastern and western medicine, and is also a practitioner of acupuncture and instructor of tai chi. Dr. Lee will speak about how she integrates both medical approaches into her practice, and the benefits these techniques provide to her patients.

Living to 100: Lessons in Living to Your Maximum Potential
with Dr. Thomas Perls
** in Cary Hall - 1605 Massachusetts Ave **
Sunday, November 14 - 2:00 p.m.

Dr. Perls is a physician and researcher in the study of aging at Boston University Medical School and cares for older patients at Boston Medical Center. For the past eight years he has directed the New England Centenarian Study (NECS).

Centenarians have a history of aging very slowly and have either markedly delayed or entirely escaped diseases normally associated with aging such as Alzheimer's disease, cancer, stroke and heart disease. Though genetics plays an important role in getting to 100, the centenarian study and its collaborators show how it may be possible for people to live to their late eighties in exceptional health.